Does Sivextro Require Kidney Dose Adjustments?
Sivextro (tedizolid phosphate) needs no dose adjustments for patients with kidney problems, including severe impairment or end-stage renal disease. The standard adult dose is 200 mg once daily for 6 days to treat acute bacterial skin infections.[1]
How Does Kidney Function Affect Sivextro Clearance?
Tedizolid is mostly eliminated through the liver and non-renal pathways—about 82% of the dose exits via feces and only 18% via urine, mostly as inactive metabolites. Kidney impairment has minimal impact on exposure levels, so pharmacokinetics remain similar across mild, moderate, severe, and dialysis-dependent patients.[1][2]
What About Patients on Hemodialysis?
No changes needed. Tedizolid isn't significantly removed by hemodialysis, and post-dialysis dosing follows the regular schedule.[1]
Sivextro Safety Profile in Kidney Impairment
Clinical trials and studies confirm similar tolerability in patients with kidney issues versus those with normal function. Common side effects like nausea, headache, diarrhea, and vomiting occur at comparable rates (3-5%). No increased risk of serious adverse events tied to renal status.[1][2]
Warnings or Monitoring for Kidney Patients?
Monitor for general side effects, but no specific kidney-related precautions beyond standard use. Avoid in patients with hypersensitivity to tedizolid. Use caution with myelosuppressive drugs due to potential blood count effects, unrelated to kidneys.[1]
[1]: Sivextro Prescribing Information (Merck)
[2]: DrugPatentWatch.com - Sivextro (Tedizolid) Dosing and Renal Impairment